MedPath

effect of supplement containing Astaxanthin and alpha linolenic acid in coronary artery stenosis

Early Phase 1
Conditions
Atherosclerotic heart disease
Cardiovascular disease.
Registration Number
IRCT2016050327727N1
Lead Sponsor
Vice chancellor for research, Ahvaz Jundishapour University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
44
Inclusion Criteria

Willingness to participate in the study; age range over 18 years; Patients who are suffering from ischemic heart disease with 30 -70 percent stenosis and are not candidates for coronary angioplasty.
Exclusion criteria: having chronic disease; Blood or immunologic disorders; Hypothyroidism; Cardiogenic shock; Myocardial infarction with elevation of ST-segment; Pregnant and lactating women.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath